J&J eyes ‘imminent’ coronavirus vaccine production, aims for a billion doses worldwide

J&J eyes ‘imminent’ coronavirus vaccine production, aims for a billion doses worldwide

Johnson & Johnson (JNJ) said on Tuesday it plans to begin imminent production of its trial COVID-19 vaccine on an “at risk” basis, as the coronavirus pandemic infects nearly 2 million people around the world. Manufacturing “at risk” allows the world’s third largest pharmaceutical company to produce a product before its ultimate design is finalized […]